July 26, 2020 / 2:49 PM / 17 days ago

BRIEF-Moderna Announces Expansion Of Barda Agreement To Support Larger Phase 3 Program For Vaccine Against COVID-19

July 26 (Reuters) - Moderna Inc:

* MODERNA ANNOUNCES EXPANSION OF BARDA AGREEMENT TO SUPPORT LARGER PHASE 3 PROGRAM FOR VACCINE (MRNA-1273) AGAINST COVID-19

* MODERNA-ADDITIONAL FUNDING TO SUPPORT EXPANDED MRNA-1273 CLINICAL DEVELOPMENT PLAN INCLUDING 30,000 PARTICIPANT PHASE 3 COVE STUDY CONDUCTED WITH NIH

* MODERNA-ADDITIONAL FUND OF UP TO $472 MILLION TO SUPPORT PHASE 3 STUDY OF CO’S MRNA VACCINE CANDIDATE AGAINST COVID-19

* THE TOTAL VALUE OF AWARD IS NOW APPROXIMATELY $955 MILLION

* MODERNA - CO REMAINS ON TRACK TO BE ABLE TO DELIVER ABOUT 500 MILLION DOSES PER YEAR, AND POSSIBLY UP TO 1 BILLION DOSES PER YEAR, BEGINNING IN 2021 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below